ABSTRACT: Local anesthetics (LA) are among the drugs most frequently used for musculoskeletal problems, in procedures ranging from diagnosis to postoperative pain control. Chondrocyte toxicity induced by LA is an emerging area of concern. The purpose of this study was to determine whether N-acetyl cysteine (NAC), an antioxidant, will exert cytoprotective effects against chondrocyte death induced by LA. Primary cultured human chondrocytes were used for this study. This study used control, NAC, LA, and NAC-LA groups. Cytotoxicity was induced in the LA subgroups and their paired NAC-LA subgroups through exposure to ropivacaine (0.075%), bupivacaine (0.05%), or lidocaine (0.2%) for 24 h. The NAC-LA subgroups were exposed to 10 mM NAC for 1 h, before LA exposure. These study groups were evaluated for rates of cell viability, apoptosis, necrosis, intracellular ROS production, and caspase-3/7 activity. Cell viability in all LA subgroups was significantly lower than in the control group (p < 0.001). Cell viability in the NAC-LA subgroups was significantly higher than in their paired LA subgroups (p < 0.001). In the LA subgroups, rates of apoptosis and necrosis, intracellular ROS production, and caspase-3/7 activity were significantly higher than in the control group (p 0.029). In the NAC-LA subgroups, rates of apoptosis and necrosis, intracellular ROS production, and caspase-3/7 activity were significantly lower than in their paired LA subgroups (p 0.023). These results indicate that N-acetyl cysteine, an antioxidant, has cytoprotective effects against LA-induced toxicity to chondrocytes in vitro. Intra-articular injection of LA is widely used to control pain following arthroscopic surgery. However, intraarticular local anesthetic injection has been reported to be a cause of chondrolysis after arthroscopic surgery. [5] [6] [7] [8] It is known that commonly used LA has a cytotoxic effect on chondrocytes.
Local anesthetics (LA), such as ropivacaine, bupivacaine, and lidocaine, are among the drugs most frequently used for postoperative pain management. [1] [2] [3] [4] Intra-articular injection of LA is widely used to control pain following arthroscopic surgery. However, intraarticular local anesthetic injection has been reported to be a cause of chondrolysis after arthroscopic surgery. [5] [6] [7] [8] It is known that commonly used LA has a cytotoxic effect on chondrocytes. [9] [10] [11] [12] [13] Even a single intra-articular 0.5% bupivacaine injection can reduce chondrocyte density without cartilage tissue loss. 9 Several studies have proposed that the cytotoxic mechanism of LA-induced chondrotoxicity is related to the activation of p53, the increased formation of intracellular reactive oxygen species (ROS), and the increased activation of caspase-3. [14] [15] [16] A few studies have investigated the possibility of avoiding LAinduced chondrocyte death by using opioid injections instead of LA injections. 17 One study suggested that apoptosis inhibition may be an effective strategy for minimizing chondrocyte death after exposure to LA. 18 However, no study has suggested any other method of protecting chondrocytes from the adverse effects of LA.
N-acetyl cysteine (NAC), a widely used thiolcontaining compound, is one of the major intracellular antioxidant precursors of glutathione (GSH); NAC is also a substrate for the synthesis of GSH and a reducer of lipid peroxidation. 19 NAC currently has many clinical uses, among them: In the treatments of paracetamol intoxication, contrast-induced nephropathy, and chronic obstructive pulmonary disease, and as a mucolytic in the treatment of HIV. 20, 21 Recently, NAC has been found also to exert an antiapoptotic effect by inhibiting oxidative stress-induced cell death. 16, [22] [23] [24] The purposes of the current study were to determine whether this well-known antioxidant, NAC, has cytoprotective effects on LA-induced chondrocyte cell death and, if so, to evaluate NAC's cytoprotective mechanism.
MATERIALS AND METHODS

Study Design
This study used a control group, an NAC group, an LA group, and an NAC-LA group. Cytotoxicity was induced in the LA subgroups and their paired NAC-LA subgroups through exposure to ropivacaine (0.075%), bupivacaine (0.05%), or lidocaine (0.2%) for 24 h. The exposure time for the LA was determined by the results of the preliminary study; it was selected to yield mortality rates ranging from 30% to 50% (mean 30.05 AE 3.53% in 0.075% ropivacaine, mean 45.55 AE 2.88 in 0.05% bupivacaine, and mean 46.40 AE 1.33 in 0.2% lidocaine). The NAC-LA subgroups were exposed to 10 mM NAC for 1 h, before LA exposure. These study groups were evaluated for rates of cell viability, apoptosis, necrosis, intracellular ROS production, and caspase-3/7 activity.
Human Chondrocyte Culture
The human cartilage tissues were collected from four patients undergoing shoulder arthroplasty for proximal humeral fractures or irreparable rotator cuff tears (a 64-year-old man, a 64-year-old woman, a 68-year-old woman, and a 77-year-old man). Those harvested cartilage tissues were obtained during 2014, with the permission of the Institutional Review Board (GNUHIRB-2014-07-023). Briefly, the tissues were washed twice with PBS (Lonza, MD), then minced into small pieces with a sterile scalpel, and placed on a six-well tissue culture plate (Corning, NY), in DMEM/F-12 (Gibco, Grand Island, NY) supplemented with 10% FBS (Gibco), and treated with 1% AntibioticAntimycotic (Gibco) in a humidified 5% CO 2 atmosphere at 37˚C. To allow for sufficient expansion of cells, the thirdpassage cells were used for all the experiments.
Cell-Viability Analyses
The cell-viability analysis using CCK-8 kit assay (Dojindo, Kumamoto, Japan) was performed as follows. Chondrocytes (2 Â 10 4 ) were seeded in each well of a 24-well plate. The cells were maintained in an incubator at 5% CO 2 , 37˚C for 24 h. Briefly, a 15 ml solution of CCK-8 kit was added to each well of the 24-well plate. After the cells were moved to a 96-well plate, absorbance was measured at 450 nm with a microplate reader. Cell-viability was expressed as a percentage of live cells, compared with the control set at 100%.
The cell-viability analysis using a contrast microscope was performed as follows. Chondrocytes (1 Â 10 5 ) were seeded in each well of a six-well plate. The cell morphology of chondrocytes was observed (40Â magnification), using an inverted phase contrast microscope.
Apoptosis Analyses
Cell-viability analyses were performed, using a fluorescein isothiocyanate (FITC) Annexin V-PI kit (BD Biosciences, San Diego, CA), according to the manufacturer's instructions. Using flow cytometry (Cytomics FC500, Beckman, CA) cellviability was determined as follows: Live cells were labeled with neither stain; apoptotic cells were labeled only with Annexin V; and necrotic cells were labeled with both Annexin V and PI. DAPI (4 0 , 6-diamidino-2-phenylindole) staining for evaluation of DNA fragmentation was performed as follows. The cells were fixed with methanol for 5 min at À20˚C, and then were washed with cold PBS. The cells were kept in 1% triton X-100 in PBS solution for 10 min at room temperature, and then were washed with PBS. The cells were stained with DAPI staining solution (1 mg/ml, Sigma, St. Louis, MO) for 5 min at 37˚C, and then were washed with PBS. The cells were evaluated using a fluorescence microscope (Olympus, Japan).
Intracellular ROS Production Analyses
The intracellular ROS generation induced by LA was assessed using FACS and a confocal microscope. The measurement of intracellular ROS production using FACS (Cytomics FC500) was performed as follows. Chondrocytes (1 Â 10 5 ) were seeded in each well of a six-well cell culture plate. The cells were incubated with DCF-DA (2 0 , 7 0 -Dichlorofluorescin diacetate) solution (5 mM, Sigma) for 15 min at 37˚C; they were then washed, and resuspended in PBS. Intracellular ROS products were measured using FACS. Data were analyzed using CXP software (Beckman, CA).
The intracellular ROS production was assessed qualitatively using a confocal microscope, as follows. Chondrocytes (1 Â 10 4 ) were seeded on the cover glass of each well of a 24-well cell culture plate. The cells were incubated with 5 mM DCF-DA solution for 15 min at 37˚C, and then were washed with PBS.
After the addition of free serum medium, each cover glass was moved to a confocal dish. The intracellular ROS production was analyzed, using a laser-scanning confocal imaging system (Olympus IX70, Olympus, Tokyo, Japan). Chondrocytes (3 Â 10 3 ) were seeded in each well of 96-well cell culture plate; then the chondrocytes were incubated for 24 h. Then, caspase-3/7 activity was measured, using a Caspase-Glo 1 3/7 Assay Kit, according to the manufacturer's guide (Promega, Madison, WI).
Caspase-3/7 Activity Analyses
Statistical Analyses
Each experiment was performed at least three times, and the results were presented as the mean of the total number of trials performed, in order to obtain more objective data. All values were expressed as mean AE SD. All statistical analyses were performed via one-way ANOVA, followed by Tukey's post hoc test. Differences with a probability of less than 0.05 were considered statistically significant. All statistical analyses were done by SPSS 17.0 for Windows (SPSS, Chicago, IL).
RESULTS
Cell-Viability Analyses
Cell-viability in all the LA subgroups was significantly lower than in the control group (p < 0.001). However, cell-viability in the NAC-LA subgroups was significantly higher than in their paired LA subgroups (p < 0.001) (Fig. 1A) . Morphological analyses using a phase contrast microscope confirmed markedly higher cell populations in the NAC-LA subgroups than in their paired LA subgroups (Fig. 1B) .
Apoptosis Analyses
According to the FACS using Annexin V-PI double staining, the mean percentages of apoptotic, and necrotic cells in the LA subgroups were higher than in the control group (apoptotic cell, bupivacaine and lidocaine (Fig. 2A) .
DAPI staining analyses, which were used to determine the morphological characteristics of the apoptotic cells, showed higher numbers of cells with DNA fragmentation in the LA subgroups than in the control group (Fig. 2B) . The numbers of cells with DNA fragmentation were considerably lower in the NAC-LA subgroups than in their paired LA subgroups.
Intracellular ROS Production Analyses
According to the FACS analyses, the levels of intracellular ROS production in the LA subgroups were significantly higher than in the control group (ropivacaine, p ¼ 0.029; bupivacaine, p ¼ 0.002; lidocaine, p ¼ 0.001). All of the NAC-LA subgroups showed significantly lower intracellular ROS production than (Fig. 3A) . According to the confocal microscope analyses, intracellular ROS production in all of the LA subgroups was higher than in the control and higher than in their paired LA subgroups (Fig. 3B ).
Caspase-3/7 Activity Analyses
Caspase-3/7 activity in each of the LA subgroups was higher than in the control group (ropivacaine and bupivacaine: p 0.001). Caspase-3/7 activity in all of the NAC-LA subgroups was significantly lower than in their paired LA subgroups (p 0.004) (Fig. 4) .
DISCUSSION
The notable finding of this study was that NAC exerts cytoprotective effects against LA-induced cytotoxicity to chondrocytes. NAC achieved these effects by reducing intracellular ROS production and caspase 3/7 activity.
According to the cell-viability analyses performed in the current study, LA significantly induced chondrocyte death. Several previous studies reported that exposure of primary human chondrocytes to LA induced chondrocyte death by apoptosis and necrosis in a dose-and time-dependent manner. 13, 25, 26 Therefore, this study confirmed the results of the previous studies.
In the current study, FACS analyses using annexin V-PI double staining demonstrated that the rates of apoptosis and necrosis in LA subgroups were significantly higher than those of the control group. All of the NAC-LA subgroups had lower rates of apoptosis and necrosis than the paired LA subgroups. The DAPI-stain, 27 which indicates apoptosis by displaying condensed chromatin or fragmented nuclei, demonstrated a greater abundance of apoptotic cells in the LA subgroups than in the control group. The number of DAPI-stained cells with DNA fragmentation was considerably lower in each NAC-LA subgroup than in its paired LA subgroup. These findings of the current study strongly suggest that NAC had antiapoptotic effects against the LA-induced apoptotic death of chondrocytes. Farkas et al. 15 reported that chondrocytes exposed to lidocaine showed more apoptosis than the control group, but the chondrocytes exposed to ropivacaine or bupivacaine showed more necrosis than the control. Grishko et al. 28 reported that in vitro 
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exposure of human chondrocytes to lidocaine, bupivacaine, or ropivacaine increased the induction of apoptosis. Park et al. 26 reported that bupivacaine and lidocaine increased chondrotoxicity, which was induced primarily by necrosis rather than apoptosis. Several studies [29] [30] [31] have suggested that LA may affect mitochondrial energetics and that mitochondrial insults can induce either necrosis or, in the less severe injuries, apoptosis. The current study supports the previous studies' findings that local anesthetics induce chondrocyte death by mechanisms that include apoptosis and necrosis.
This study showed that intracellular ROS production was increased by exposure to LA and that the increased ROS production significantly reduced pretreatment of NAC. Both apoptosis and necrosis are known to be induced by oxidative stress. ROS production induces damage to lipids, proteins, and nucleic acids in mitochondria. ROS-induced mitochondrial DNA (mtDNA) damage and mutations lead to the synthesis of functionally impaired respiratory chain subunits, causing respiratory chain dysfunction and augmented ROS production. 32, 33 This vicious cycle has been proposed as a cause to exponential increase in mtDNA damage and mutations over time, which result in functional failure and cell death. 34 Park et al. 35 reported that NAC and trolox (a water-soluble derivative of vitamin E) reduced bupivacaine-induced ROS production and these antioxidants also reduced bupivacaine induced Schwann cell death. Another study investigating myotubes reported that ROS production induced by bupivacaine was inhibited by treatment of antioxidants, including NAC, trolox, and resveratrol in a dose-dependent manner. 36 The current study and previous studies suggested that, through its scavenging activity against intracellular ROS production induced by LA, NAC has effects that protect cells.
In this study, caspase 3/7 activity was increased by exposure to LA and that response was decreased by NAC. Caspase-3 is a recognized executioner that uses both the intrinsic and extrinsic apoptosis pathways. 37 Breu et al. 38 demonstrated that caspase 3/7 activity increased in human chondrocytes after exposure to bupivacaine, ropivacaine, and mepivacaine, and they suggested that the increased caspase 3/7 activity was a mechanism of cell death. Grishko Figure 2 . (A) According to the FACS analyses using Annexin V-PI double staining, the rates of apoptosis and of necrosis were higher in all the LA subgroups than in the control. However, the rates of apoptosis and of necrosis in all the NAC-LA subgroups were lower than in their paired LA subgroups. (B) The morphological analyses using DAPI staining demonstrated both that local anesthetics induced DNA fragmentation (a marker for apoptosis) and that the rates of DNA fragmentation were markedly decreased in the NAC-LA subgroups. 300 KIM ET AL. et al. 28 reported that caspase-3 and caspase-9 increase in human chondrocytes following LA exposure, which induced apoptosis of chondrocytes. Rao et al. 18 demonstrated that the LA increase the activity of caspase-3 in chondrocytes, and the LA-induced chondrocyte death was significantly reduced after treatment of pan-caspase inhibitor (z-vad-fmk). That study reported that caspases play a potential role in LA induced chondrocyte death. The current study supports these previous studies' results regarding LA-activated caspase-3 and -7. The current finding supports the previous studies' reports of some evidence that antioxidants prevent LA-induced dysfunctions by inhibiting the activation of caspase-9, -7, and -3, and the cleavage of PARP. 35, 36 The antioxidants which have been reported to reduce LAinduced cytotoxicity of myoblasts or of neuroblasts are NAC, Resveratrol, and alpha-lipoic acid. 36, 39 However, determining whether these antioxidants' cytoprotective effects are a general pharmacological characteristic or a cell-specific finding will require further study. The morphological analyses by confocal microscope also demonstrated that intracellular ROS levels were higher in the LA subgroups than in the control and that intracellular ROS levels were markedly lower in the NAC-LA subgroups than in their paired LA subgroups.
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The current experiment has several limitations. We did not evaluate NAC's effects on caspaseindependent apoptosis. We did not evaluate whether NAC has any effects on the anesthetic potency or efficacy of LA. Therefore, further studies should address these issues. Also, it should be noted that we did not perform studies on normal chondrocytes obtained from healthy donors, but rather on osteoarthritic chondrocytes; these, being already stressed, may not have been able to recover as well as normal cells. Nonetheless, NAC exerted cytoprotective effects against LA-induced cell death, even in these stressed chondrocytes. Because the purpose of the current study was limited to demonstrating the ability of an antioxidant to reduce LA-induced chondrocyte death, we did not evaluate the cytoprotective abilities of various concentrations of NAC or NAC's durability as an antioxidant. In order to proceed toward clinical usefulness for protection of cells from LA-induced cytotoxicity, that issue should be addressed in further research. Future studies will additionally have to determine the best way to introduce the antioxidant and the local anesthetic into the joint, such as by simultaneous injection. Finally, because the current study was an in vitro experiment, we are simply unable to extrapolate conclusions applicable to in vivo experiments. However, by laying the groundwork for further preclinical or clinical studies, this in vitro study contributes to the eventual attainment of clinically applicable research findings regarding the prevention of LA-induced chondrocyte toxicity.
CONCLUSION
N-acetyl cysteine (NAC), an antioxidant, has cytoprotective effects against LA-induced toxicity to chondrocytes in vitro.
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